Stay updated on DUR-928 in SARS-CoV-2-Related Organ Injury Clinical Trial
Sign up to get notified when there's something new on the DUR-928 in SARS-CoV-2-Related Organ Injury Clinical Trial page.

Latest updates to the DUR-928 in SARS-CoV-2-Related Organ Injury Clinical Trial page
- Check3 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference3%
- Check10 days agoChange DetectedThe web page has been updated to a new version, v2.16.0, replacing the previous version v2.15.2.SummaryDifference0.5%
- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.2%
- Check46 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study information regarding the safety and efficacy of DUR-928 in COVID-19 patients, and an update to the version number of the study documentation.SummaryDifference14%
- Check53 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.2%
- Check97 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference3%
Stay in the know with updates to DUR-928 in SARS-CoV-2-Related Organ Injury Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DUR-928 in SARS-CoV-2-Related Organ Injury Clinical Trial page.